This site is intended for Healthcare professionals only.
×

Novo Nordisk says Victoza helps lower heart risks

Novo Nordisk says Victoza helps lower heart risks

Copenhagen: Novo Nordisk said on Friday the results from a trial showed that its Victoza diabetes drug significantly reduced the risks of major adverse cardiovascular events.

“People with type 2 diabetes generally have a higher risk of experiencing major adverse cardiovascular events. That’s why we are very excited about the results from LEADER (trial), which showed that Victoza … also reduces their risk of major adverse cardiovascular events,” Novo’s Chief Science Officer Mads Krogsgaard Thomsen said.

Novo Nordisk’s shares jumped as much as 7 percent in the minutes after the announcement.

0 comment(s) on Novo Nordisk says Victoza helps lower heart risks

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted
    Source: Reuters

    Opinion Polls

    Should Government Doctors be allowed to do Private Practice?